Novartis Lecture in Organic Chemistry: Design and Evolution of New Biocatalysts for Enantioselective Synthesis
Seminar | February 14 | 11 a.m.-12 p.m. | Pitzer Auditorium, 120 Latimer Hall
This lecture will describe recent work from our laboratory aimed at developing new biocatalysts for enantioselective organic synthesis, with a particular emphasis on the design of in vitro and in vivo cascade processes for generating chiral pharmaceutical building blocks. By applying the principles of biocatalytic retrosynthesis we have shown that is now increasingly possible to design new synthetic routes to target molecules in which biocatalysts are used in the key bond forming steps.
The integration of several biocatalytic transformations into multi-enzyme cascade systems, both in vitro and in vivo, will be addressed in the lecture. In this context monoamine oxidase (MAO-N) has been used in combination with other biocatalysts and chemocatalysts in order to complete a cascade of enzymatic reactions. Other engineered biocatalysts that can be used in the context of cascade reactions include -transaminases, phenylalanine ammonia lyases, amine dehydrogenases, imine reductases , and artificial transfer hydrogenases. We shall also present some very recent work aimed at the development of a new biocatalyst for enantioselective reductive amination and show how these enzymes can be used to carry out redox neutral amination of alcohols via hydrogen borrowing.
Light refreshments served at The Coffee Lab at 10:50am.